Key result
Assignment to a hybrid mHealth digital disease management platform decreased the likelihood of 45-day hospital readmission by 78% compared to control in patients with congestive heart failure.
Why the study?
Congestive heart failure has a particularly high readmission rate in elderly patients, and mobile health presents a promising pathway to reduce readmissions.
Does a hybrid mHealth model reduce 45-day hospital readmissions in patients diagnosed with congestive heart failure?
RCT
Does a hybrid mHealth model reduce 45-day hospital readmissions in patients diagnosed with congestive heart failure?
Effect estimate: 78% decrease in likelihood
A hybrid mHealth model integrating remote patient monitoring and digital disease management significantly reduces 45-day hospital readmissions in patients with congestive heart failure.
Supports hybrid mHealth adoption in HF care to lower readmissions; confirms RCT efficacy of digital disease management.
Congestive heart failure (CHF) is one of the most common diagnoses in the elderly United States Medicare (⩾ age 65) population. This patient population has a particularly high readmission rate, with one estimate of the 6-month readmission rate topping 40%. The rapid rise of mobile health (mHealth) presents a promising new pathway for reducing hospital readmissions of CHF, and, more generally, the management of chronic conditions. Using a randomized research design and a multivariate regression model, we evaluated the effectiveness of a hybrid mHealth model-the integration of remote patient monitoring with an applied health technology and digital disease management platform-on 45-day hospital readmissions for patients diagnosed with CHF. We find a 78% decrease in the likelihood of CHF hospital readmission for patients who were assigned to the digital disease management platform as compared to patients assigned to control.
No takes yet. Share an insight, caveat, or question.
Gjeka et al. (2021) conducted an RCT in Congestive heart failure. Hybrid mHealth model (digital disease management platform) vs. Control was evaluated on 45-day hospital readmissions (78% decrease in likelihood). Assignment to a hybrid mHealth digital disease management platform decreased the likelihood of 45-day hospital readmission by 78% compared to control in patients with congestive heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: